According to the new market research report "Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) - Global Forecast to 2026", published by MarketsandMarkets™, the global Animal Antimicrobials Market is projected to reach USD 5.6 billion by 2026 from USD 4.7 billion in 2021, at a CAGR of 3.6% from 2021 to 2026.
Browse in-depth TOC on "Animal
Antibiotics and Antimicrobials Market"
151 – Tables
35 – Figures
152 – Pages
Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353
The animal antibiotics market growth can largely be
attributed to the rising demand for animal-derived food products, increasing
incidence of zoonotic diseases, and the implementation of regulations to
prevent the spread of animal diseases. Rising animal healthcare spending and
the growing demand for pet insurance are further expected to drive the growth
of this market. The untapped emerging markets such as China, India,
and Brazil and
growth in the overall companion animal population are also expected to offer
significant growth opportunities to market players in the coming years.
However, the limited number of new antibiotics,
growing resistance to antimicrobials and antibiotics, and increasing good
husbandry and hygiene practices are expected to hinder the growth of this
market to a certain extent.
The Tetracyclines segment accounted for the largest
market share in 2020.
Based on products, the global animal antimicrobials
and antibiotics market is segmented into tetracyclines, penicillins,
sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones,
cephalosporins, and other antimicrobial and antibiotic products. In 2020, the
tetracyclines segment accounted for 48.9% of the global animal antimicrobials
market. Tetracyclines exhibit advantages such as the highest potency against
pathogenic microorganisms, are well-absorbed, show low toxicity, and are
relatively inexpensive compared to other animal antimicrobial and antibiotic products.
These advantages contribute to the large share of this product segment. The
fluoroquinolones segment is expected to grow at the highest CAGR of 8.0% during
the forecast period. Advantages such as higher efficacy at low concentrations,
quick penetration through tissues, and the availability of variations in the
route of administration result in the higher adoption of fluoroquinolones among
end users.
The Premixes segment accounted for the largest
market share in 2020.
Based on the mode of delivery, the global animal
antimicrobials and antibiotics market is segmented into premixes, oral powders,
oral solutions, injections, and other modes of delivery. In 2020, the premixes
segment accounted for the largest share of 46.3% of the global animal
antibiotics market. The large share of this segment can be attributed to the
advantages of premixes, such as simplified mode of administration and lower
instability and hygroscopicity of formulations. The injections segment is
expected to witness the highest CAGR of 4.9% during the forecast period.
Advantages such as immediate delivery of drugs and rapid onset of drug effects
are expected to drive growth in this market.
The food producing animal segment accounted for the
largest market share in 2020.
Based on animal type, the global animal
antimicrobials and antibiotics market is categorized into food-producing
animals and companion animals. In 2020, the food-producing animals segment
accounted for the largest share of around 73.4%. This segment is also expected
to register the highest CAGR of 3.9% during the forecast period. The large
share of this segment is mainly due to the rising demand for animal-derived
food products, increase in animal healthcare expenditure, and greater concerns
about zoonotic diseases.
Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=25161353
North
America was the largest regional market for animal
antibiotics market in 2020
The animal antimicrobials and antibiotics market is
segmented into five major regions: North
America, Europe, Asia Pacific, Latin America,
and the Middle East & Africa.
In 2020, North America accounted
for the largest share of 30.3% of the global animal antimicrobials market. The
large share of this region is mainly due to the increase in the region's animal
population, rising demand for animal-derived food products, growth in pet
insurance, and rising animal health expenditure compared to other regions.
The Asia
Pacific region is projected to grow at the highest
CAGR of 5.4% during the forecast period. Factors such as the rapidly increasing
animal population and rising demand for animal-derived food products are
driving the growth of this market in the APAC.
Some of the prominent players in the animal
antimicrobials and antibiotics market are Boehringer Ingelheim (Germany),
Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro
Animal Health (US), Virbac (France),
Vetoquinol S.A. (France),
Ceva Santé Animale (France),
Dechra Pharmaceuticals Plc (UK), Kyoritsu Seiyaku (Japan),
Tianjin Ringpu (China),
HIPRA (Spain),
Zydus Animal Health (US), China Animal Husbandry (China),
and Inovet (Belgium).
Browse Related Reports:
Animal Growth
Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic
(Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics),
Animal (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2026
No comments:
Post a Comment